Baxter International Inc. (BAX) — Free Cash Flow Yield
Healthcare
Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space comprising operating room integration technologies, precision positioning devices, and other accessories. The company also provides specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services. Its products are used in hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, kidney dialysis centers, and patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. It operates in Eastern Europe, the Middle East, Africa, Latin America, Asia, Western Europe, Canada, Japan, Australia, and New Zealand. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.
| Metric | Value |
|---|---|
| FCF Yield | 2.3% |
| Healthcare Sector Avg FCF Yield | 4.9% |
| Annual Free Cash Flow | $323M |
| Market Cap | $13.8B |
Baxter International Inc.'s FCF yield of 2.3% is below the Healthcare sector average (4.9%).
Frequently Asked Questions
What is Baxter International Inc.'s (BAX) free cash flow yield?
Baxter International Inc.'s (BAX) free cash flow yield is 2.3%. That is below the Healthcare sector average (4.9%).
Is BAX's free cash flow yield good?
At 2.3%, BAX's free cash flow yield is considered weak — yields above 10% are generally excellent, 7–10% good, 4–7% fair, and below 4% weak, though context varies by sector and growth stage.
How much free cash flow does Baxter International Inc. generate?
Baxter International Inc. generated $323M in free cash flow, against a market cap of $13.8B.
How is free cash flow yield calculated?
Free cash flow yield = (Free Cash Flow ÷ Market Capitalization) × 100%. Free cash flow equals operating cash flow minus capital expenditures.
Data from public filings. Not investment advice. Calculate your own FCF yield →